Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
At Great Clips, we believe everyone deserves an experience that makes them feel welcomed and supported
In a 72-week clinical trial, participants with diabetes receiving the highest tirzepatide dose (15 mg) lost an average of nearly 21% of their starting body weight
Personalized Alternatives: Continuing Therapy with PlexusDx For patients concerned about weight regain, continuing GLP-1 or GLP-1/GIP therapy is a well-documented long-term strategy supported by cardiovascular and metabolic outcome trials
These occur in a significant proportion of patients, particularly during dose escalation
Those receiving 5 mg, 10mg, and 15 mg experienced an average reduction of 7.6 kg (about 17 pounds), 9.3 kg (about 20 pounds), and 11.2 kg (about 25 pounds) respectively
US$ 29.85
US$ 20.00
.jpg)
US$ 26.80
